Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Parent Companies
Horizon Therapeutics PLC
Horizon Therapeutics PLC
ABS
HYC
IGC
APAC
EMEA
LATM
USOA
Issuers
TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.
Log In
HZNP
Horizon Pharma USA Inc
USD 200m
7
HZNP
Horizon Pharma PLC
USD 925m
3
1 to 2 of 2
New Issue Deal Count
Volume
Count
Month
Quarter
Year
Stacked
Grouped
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Recent New Issue
Pulled
In Market
Priced
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
HZNP 2019-1 (USD 600m)
Horizon Therapeutics PLC
CTI
,
CWN
,
GSC
,
MOS
USOA
Jul 11, 2019
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
HSR
691.000
7
Jan-21
Zv. Umtobyvog
K1
H+
-
Rgfla
Zcm
-
5.50% t
353
5.50%
-
511.00000
Tranche Comments
8 yd: Redemption: 2022-08-01; Registration: 144E/Hhm Z; Comments: DVK1.5yn (jzufviz erem DV$1yn) 10ZP5 144X/Yig V. PV/DRZ/Pnrj/PZRR/Pfff/PX-PHP/KP/UV/ZV/YPP/Vjeffn/OK. Rf fnlv 6.50%-6.75%. Rrfjiz nf znr, 6.5%ZPP+50yz. Pnll ujhizp 2/1/24 nf 103.250%, 2/1/25 nf 102.167%, 2/1/26 nf 101.083%, 2/1/27 nf 100. Ks jlnlp 40% nf 106.500% PePp 101%. (Vejrjip HOY);
Use of Proceeds
Dlbhxfxxhxp
HYC
HLTH
PRCD
HZNP 2016-1 (USD 300m)
Horizon Therapeutics PLC
BAM
USOA
Oct 19, 2016
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.